Please use this identifier to cite or link to this item:
https://ninho.inca.gov.br/jspui/handle/123456789/12911
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Instituto Nacional de Câncer José Alencar Gomes da Silva | - |
dc.contributor.author | Instituto Nacional de Câncer (Brasil) | - |
dc.contributor.author | INCA | - |
dc.date.accessioned | 2023-03-01T15:44:38Z | - |
dc.date.available | 2023-03-01T15:44:38Z | - |
dc.date.issued | 2022-11 | - |
dc.identifier.uri | https://ninho.inca.gov.br/jspui/handle/123456789/12911 | - |
dc.publisher | INCA | pt_BR |
dc.subject | Serviço de Farmácia Hospitalar/tendências | pt_BR |
dc.subject | Pharmacy Service, Hospital/trends | pt_BR |
dc.subject | Servicio de Farmacia en Hospital/tendencias | pt_BR |
dc.subject | Congresso | pt_BR |
dc.subject | Congress | pt_BR |
dc.subject | Congreso | pt_BR |
dc.subject | Dias, Claudia de Oliveira Passos | pt_BR |
dc.subject | Antineoplásicos | pt_BR |
dc.subject | Assistência Farmacêutica | pt_BR |
dc.subject | Pharmaceutical Services | pt_BR |
dc.subject | Servicios Farmacéuticos | pt_BR |
dc.title | Congresso debate os desafios da farmácia oncológica | pt_BR |
dc.title.alternative | Informe INCA 425 | pt_BR |
dc.Type | Article | pt_BR |
Appears in Collections: | Informe Inca 425 |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Informe-INCA-2022-425-4-Congresso-debate-os.pdf | 298.01 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.